Benapenem

百纳培南

Report date: 2025/08/19 20:00:08
NME

Base Information

Drug NameBenapenem
Drug Alias NameBenapenumKBP-5081
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibioticsSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsPyelonephritisUrinary Tract InfectionsIntraabdominal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesShandong Xuanzhu Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Xuanzhu Pharmaceutical Technology Co LtdShanghai Sph New Asia Pharmaceutical Co Ltd
Inactive CompaniesSihuan Pharmaceutical Holdings Group LtdBeijing Sihuan Pharmaceutical Co Ltd
Active IndicationsUrinary Tract Infections
Inactive IndicationsPyelonephritisIntraabdominal InfectionsHealthcare-Associated Pneumonia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A